Epigallocatechin-3-gallate (EGCG) attenuates concanavalin A-induced hepatic injury in mice

Acta Histochemica

Volumn 116, Issue 4, 2014, Pages 654-662

  Liu, Dongmei ^a   Zhang, Xiaoli ^a   Jiang, Li ^a   Guo, Yun ^a   Zheng, Changqing ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Concanavalin A; Hepatitis; Inflammation; Mice; Nuclear factor B; Oxidative stress; Toll like receptors

Indexed keywords

ALANINE AMINOTRANSFERASE; EPIGALLOCATECHIN GALLATE; GAMMA INTERFERON; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE 1; INTERLEUKIN 4; INTERLEUKIN 6; MALONALDEHYDE; MYELOID DIFFERENTIATION FACTOR 88; SUPEROXIDE DISMUTASE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; CATECHIN; CONCANAVALIN A; TOLL LIKE RECEPTOR;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INDUCTION; HEPATITIS; IMMUNOSUPPRESSIVE TREATMENT; LIVER INJURY; LIVER PROTECTION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SURVIVAL; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; DISEASE MODEL; METABOLISM; PATHOLOGY; PHYSIOLOGY; TOXIC HEPATITIS; TOXICITY;

ANIMALS; CATECHIN; CONCANAVALIN A; DISEASE MODELS, ANIMAL; DRUG-INDUCED LIVER INJURY; MALE; MICE, INBRED C57BL; OXIDATIVE STRESS; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84901019056     PISSN: 00651281     EISSN: 16180372     Source Type: Journal    
DOI: 10.1016/j.acthis.2013.12.002     Document Type: Article

References (40)

1. Blokhina O., Virolainen E., Fagerstedt K.V. Antioxidants, oxidative damage and oxygen deprivation stress: a review. Ann Bot 2003, 91. [Spec No: 179-94].
2. Cao Q.Y., Chen F., Li J., Wu S.S., Wang J., Chen Z. A microarray analysis of early activated pathways in concanavalin A-induced hepatitis. J Zhejiang Univ Sci B 2010, 11:366-377.
3. Chen Y., Sun R. Toll-like receptors in acute liver injury and regeneration. Int Immunopharmacol 2011, 11:1433-1441.
4. Czaja A.J. Understanding the pathogenesis of autoimmune hepatitis. Am J Gastroenterol 2001, 96:1224-1231.
5. Gantner F., Leist M., Lohse A.W., Germann P.G., Tiegs G. Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 1995, 21:190-198.
6. Giakoustidis D.E., Giakoustidis A.E., Iliadis S., Koliakou K., Antoniadis N., Kontos N., et al. Attenuation of liver ischemia/reperfusion induced apoptosis by epigallocatechin-3-gallate via down-regulation of NF-kappaB and c-Jun expression. J Surg Res 2010, 159:720-728.
7. Heneghan M.A., McFarlane I.G. Current and novel immunosuppressive therapy for autoimmune hepatitis. Hepatology 2002, 35:7-13.
8. Jia N., Han K., Kong J.J., Zhang X.M., Sha S., Ren G.R., et al. (-)-Epigallocatechin-3-gallate alleviates spatial memory impairment in APP/PS1 mice by restoring IRS-1 signaling defects in the hippocampus. Mol Cell Biochem 2013, 380:211-218.
9. Jiang W., Sun R., Zhou R., Wei H., Tian Z. TLR-9 activation aggravates concanavalin A-induced hepatitis via promoting accumulation and activation of liver CD4+ NKT cells. J Immunol 2009, 182:3768-3774.
10. Joo S.Y., Song Y.A., Park Y.L., Myung E., Chung C.Y., Park K.J., et al. Epigallocatechin-3-gallate inhibits LPS-induced NF-kappaB and MAPK signaling pathways in bone marrow-derived macrophages. Gut Liver 2012, 6:188-196.
11. Kimura M., Umegaki K., Kasuya Y., Sugisawa A., Higuchi M. The relation between single/double or repeated tea catechin ingestions and plasma antioxidant activity in humans. Eur J Clin Nutr 2002, 56:1186-1193.
12. Kusters S., Gantner F., Kunstle G., Tiegs G. Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A. Gastroenterology 1996, 111:462-471.
13. Lee I.T., Lin C.C., Lee C.Y., Hsieh P.W., Yang C.M. Protective effects of (-)-epigallocatechin-3-gallate against TNF-alpha-induced lung inflammation via ROS-dependent ICAM-1 inhibition. J Nutr Biochem 2013, 24:124-136.
14. Li W., Zhu S., Li J., Assa A., Jundoria A., Xu J., et al. EGCG stimulates autophagy and reduces cytoplasmic HMGB1 levels in endotoxin-stimulated macrophages. Biochem Pharmacol 2011, 81:1152-1163.
15. Mak J.C. Potential role of green tea catechins in various disease therapies: progress and promise. Clin Exp Pharmacol Physiol 2012, 39:265-273.
16. Mieli-Vergani G., Vergani D. Autoimmune hepatitis. Nat Rev Gastroenterol Hepatol 2011, 8:320-329.
17. Mizuhara H., O'Neill E., Seki N., Ogawa T., Kusunoki C., Otsuka K., et al. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. J Exp Med 1994, 179:1529-1537.
18. Nakamura K., Okada M., Yoneda M., Takamoto S., Nakade Y., Tamori K., et al. Macrophage inflammatory protein-2 induced by TNF-alpha plays a pivotal role in concanavalin A-induced liver injury in mice. J Hepatol 2001, 35:217-224.
19. Nakashima H., Kinoshita M., Nakashima M., Habu Y., Shono S., Uchida T., et al. Superoxide produced by Kupffer cells is an essential effector in concanavalin A-induced hepatitis in mice. Hepatology 2008, 48:1979-1988.
20. Negre-Salvayre A., Coatrieux C., Ingueneau C., Salvayre R. Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors. Br J Pharmacol 2008, 153:6-20.
21. Ojiro K., Ebinuma H., Nakamoto N., Wakabayashi K., Mikami Y., Ono Y., et al. MyD88-dependent pathway accelerates the liver damage of concanavalin A-induced hepatitis. Biochem Biophys Res Commun 2010, 399:744-749.
22. Paracha U.Z., Fatima K., Alqahtani M., Chaudhary A., Abuzenadah A., Damanhouri G., et al. Oxidative stress and hepatitis C virus. Virol J 2013, 10:251.
23. Ren Y., Deng F., Zhu H., Wan W., Ye J., Luo B. Effect of epigallocatechin-3-gallate on iron overload in mice with alcoholic liver disease. Mol Biol Rep 2011, 38:879-886.
24. Shirin H., Aeed H., Alin A., Matas Z., Kirchner M., Brazowski E., et al. Inhibition of immune-mediated concanavalin a-induced liver damage by free-radical scavengers. Dig Dis Sci 2010, 55:268-275.
25. Sid B., Verrax J., Calderon P.B. Role of oxidative stress in the pathogenesis of alcohol-induced liver disease. Free Radic Res 2013, 47:894-904.
26. Singh B.N., Shankar S., Srivastava R.K. Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem Pharmacol 2011, 82:1807-1821.
27. Tagawa Y., Sekikawa K., Iwakura Y. Suppression of concanavalin A-induced hepatitis in IFN-gamma(-/-) mice, but not in TNF-alpha(-/-) mice: role for IFN-gamma in activating apoptosis of hepatocytes. J Immunol 1997, 159:1418-1428.
28. Tagawa Y., Matthys P., Heremans H., Dillen C., Zaman Z., Iwakura Y., et al. Bimodal role of endogenous interleukin-6 in concanavalin A-induced hepatitis in mice. J Leukoc Biol 2000, 67:90-96.
29. Teufel A., Weinmann A., Kahaly G.J., Centner C., Piendl A., Worns M., et al. Concurrent autoimmune diseases in patients with autoimmune hepatitis. J Clin Gastroenterol 2010, 44:208-213.
30. Thangapandiyan S., Miltonprabu S. Epigallocatechin gallate effectively ameliorates fluoride-induced oxidative stress and DNA damage in the liver of rats. Can J Physiol Pharmacol 2013, 91:528-537.
31. Tiegs G., Hentschel J., Wendel A. A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest 1992, 90:196-203.
32. Tipoe G.L., Leung T.M., Liong E.C., Lau T.Y., Fung M.L., Nanji A.A. Epigallocatechin-3-gallate (EGCG) reduces liver inflammation, oxidative stress and fibrosis in carbon tetrachloride (CCl4)-induced liver injury in mice. Toxicology 2010, 273:45-52.
33. Toyabe S., Seki S., Iiai T., Takeda K., Shirai K., Watanabe H., et al. Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice. J Immunol 1997, 159:1537-1542.
34. Vergani D., Choudhuri K., Bogdanos D.P., Mieli-Vergani G. Pathogenesis of autoimmune hepatitis. Clin Liver Dis 2002, 6:727-737.
35. Wang Y., Mei Y., Feng D., Xu L. (-)-Epigallocatechin-3-gallate protects mice from concanavalin A-induced hepatitis through suppressing immune-mediated liver injury. Clin Exp Immunol 2006, 145:485-492.
36. Wolf D., Hallmann R., Sass G., Sixt M., Kusters S., Fregien B., et al. TNF-alpha-induced expression of adhesion molecules in the liver is under the control of TNFR1 - relevance for concanavalin A-induced hepatitis. J Immunol 2001, 166:1300-1307.
37. Wu D., Wang J., Pae M., Meydani S.N. Green tea EGCG, T cells, and T cell-mediated autoimmune diseases. Mol Aspects Med 2012, 33:107-118.
38. Xiao J., Ho C.T., Liong E.C., Nanji A.A., Leung T.M., Lau T.Y., et al. Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF/SMAD, PI3K/Akt/FoxO1, and NF-kappa B pathways. Eur J Nutr 2013.
39. Xu J., Zhang X., Monestier M., Esmon N.L., Esmon C.T. Extracellular histones are mediators of death through TLR2 and TLR4 in mouse fatal liver injury. J Immunol 2011, 187:2626-2631.
40. Zhong Y., Chiou Y.S., Pan M.H., Shahidi F. Anti-inflammatory activity of lipophilic epigallocatechin gallate (EGCG) derivatives in LPS-stimulated murine macrophages. Food Chem 2012, 134:742-748.